BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05064059-completion@plaintrial.com
DTSTAMP:20261029T013749Z
DTSTART;VALUE=DATE:20250221
SUMMARY:A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus
  Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Pos
 itive Colorectal Cancer (MK-4280A-007) — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT05064059
URL:https://plaintrial.com/trial/NCT05064059
END:VEVENT
END:VCALENDAR
